KYXATA (CARBOPLATIN) — FDA Approval NDA219921 (AVYXA HOLDINGS)
KYXATA (CARBOPLATIN) — FDA Approval NDA219921 (AVYXA HOLDINGS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: KYXATA; Active ingredients: CARBOPLATIN; Application number: NDA219921.
| Brand name | KYXATA |
|---|---|
| Active ingredients | CARBOPLATIN |
| Application number | NDA219921 |
| Sponsor | AVYXA HOLDINGS |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20250808 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →